Page 7 - பிராங்க்ஃபர்ட் ஸ்டாக் பரிமாற்றம் ப்ரைம் தரநிலை News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Paion : ???????PAION RECEIVES EUROPEAN COMMISSION APPROVAL OF BYFAVO(R) (REMIMAZOLAM) FOR PROCEDURAL SEDATION
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Investegate |H&R GmbH & Co KGaA Announcements | H&R GmbH & Co KGaA: Preliminary business results 2020
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Commerzbank and creditshelf Expand Strategic Cooperation
Media
Continuation of successful partnership with Commerzbank’s Corporate Clients segment that started in 2019
Expansion to Private and Small-Business Customers segment provides supplementary financing opportunities for SMEs with annual revenues of up to EUR 15 million
With immediate effect, creditshelf clients will also benefit from Commerzbank’s product range
In this way, creditshelf and Commerzbank are giving their clients access to innovative, forward-looking finance solutions
Frankfurt am Main, March 9, 2021 ‒ creditshelf Aktiengesellschaft and Commerzbank AG are deepening their strategic cooperation and expanding it to include Commerzbank’s Private and Small-Business Customers segment.
The partnership between creditshelf and Commerzbank that was launched in 2019 is to be expanded. With immediate effect, clients from Commerzbank’s Private and Small-Business Customers segment can also use creditshelf’s fi
Investegate |PAION AG Announcements | PAION AG: PAION GRANTS EXCLUSIVE LICENSE TO TTY BIOPHARM FOR DEVELOPMENT AND COMMERCIALIZATION OF REMIMAZOLAM IN TAIWAN
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Biofrontera AG announces the closing of the capital raise with gross proceeds of EUR 24.7 million
Biofrontera AGFebruary 26, 2021 GMT
Leverkusen, Germany, Feb. 26, 2021 (GLOBE NEWSWIRE) Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (“Biofrontera” or the “Company”), an international biopharmaceutical company, announces the closing of the capital increase resolved by the annual general meeting on May 28, 2020.
The capital increase was carried out by way of a subscription rights offering to existing shareholders of Biofrontera AG under German law. Unsubscribed shares were placed in the course of a public offering of American Depositary Shares (“ADS” and “ADS Offering”) in the United States. The Company raised total gross proceeds of approximately EUR 24.7 million.